ペンシルベニアにおける大うつ病性障害の臨床試験
ペンシルベニア内の拠点で、大うつ病性障害に関する27件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Adams Clinical Philadelphia, Philadelphia
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
- Suburban Research Associates, West Chester
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07775300Precision Depression Adalimumab Trial
- University of Pennsylvania, Philadelphia
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07845604Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- University of Pennsylvania, Philadelphia
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/09/25更新 · NCT06559306Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- University of Pennsylvania - Perelman School of Medicine, Philadelphia
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Adams Clinical Philadelphia, Philadelphia
- Flourish Research Philadelphia, Philadelphia
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/25更新 · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Allentown
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/14更新 · NCT07065240Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
- University of Pennsylvania, Philadelphia
被験者募集中早期第1相
25歳〜65歳 · 全性別 · 2026/09/10更新 · NCT06788249Decoding and Modulating Affective Brain States
- University of Pennsylvania, Philadelphia
被験者募集中参加者への支払いあり
18歳〜65歳 · 全性別 · 2026/09/03更新 · NCT05437705A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Allentown
- Draig Clinical Site, Media
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/02更新 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Pennsylvania Hospital, Philadelphia
被験者募集中
22歳〜70歳 · 全性別 · 2026/08/28更新 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Media
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/08/26更新 · NCT07300969Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/14更新 · NCT07226232A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Adams Clinical Philadelphia, Philadelphia
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/08/10更新 · NCT07592689NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Philadelphia
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/10更新 · NCT06963021A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Suburban Research Associates, Media
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/06更新 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Lehigh Center For Clinical Research, Allentown
- Adams Clinical - Philadelphia, Philadelphia
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/08/03更新 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Lehigh Center for Clinical Research, Allentown
被験者募集中第2相
18歳〜64歳 · 全性別 · 2026/08/03更新 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Lehigh Center for Clinical Research, Allentown
- Adams Clinical, Philadelphia
被験者募集中第2相
18歳〜64歳 · 全性別 · 2026/07/27更新 · NCT07115329A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Philadelphia
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/24更新 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Philadelphia
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/24更新 · NCT06966401Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments
- Bellefield Towers, Pittsburgh
被験者募集中
18歳〜55歳 · 全性別 · 2026/05/22更新 · NCT06976840Triage Survey for Psychiatry Research Eligibility
- Adams Clinical, Philadelphia, Philadelphia
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/20更新 · NCT05800925A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Scranton Medical Institute, LLC, Moosic
- University of Pennsylvania, Philadelphia
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/05/11更新 · NCT06524830Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
- University of Pittsburgh, Pittsburgh
被験者募集中
18歳〜55歳 · 全性別 · 2026/03/04更新 · NCT05703256Taking Action for College Students
- Temple University, Philadelphia
被験者募集中
18歳以上 · 全性別 · 2025/12/29更新 · NCT06700902Neurofeedback to Treat Depression - 2
- Center for Neuromodulation in Depression and Stress, Philadelphia
被験者募集中
18歳〜65歳 · 全性別 · 2025/12/04更新 · NCT07159061Study of ALTO-300 in MDD
- Site 216, Allentown
- Site 350, Media
- Site 352, Moosic
被験者募集中第2相
18歳〜70歳 · 全性別 · 2025/07/24更新 · NCT05922878ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。